CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 34 enrolled
Drug / intervention
Synbiotic 2000 +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00688311
NCT00688311N/ACompleted
CompareCT.gov

Pilot Trial of a Synbiotic in HIV+ Patients

University of California, Davis·interventional·Posted Jun 2, 2008·Updated Nov 23, 2009

In Brief

A clinical study evaluating Synbiotic 2000 and Placebo for HIV Infection. Completed, enrolled 34 participants across 1 site.

Detailed Summary

The goal of this study is to test the hypothesis that daily ingestion of a 'synbiotic' for 4 weeks will improve intestinal function, ease immune system overactivation, and increase blood CD4 count in HIV-infected individuals. A 'Synbiotic' is a mixture of probiotic bacteria and dietary fiber.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV Infection
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 2, 2008
Enrollment StartMay 1, 2008
Primary CompletionNov 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 18.1 years ago

Interventions

Synbiotic 2000dietary

A preparation consisting of 4 species of probiotic bacteria (10\^10 each) combined with 4 types of dietary fiber (2.5g each).

Placebodietary

Placebo